September 11, 2017 6:25pm

 

The diagnosis: questionable with a confluence of deteriorating indicators as September moves forward

As the sector opened up, slipped at the mid-day and closed positive …

 

Never forget the fallen of 9/11, our prayers still resound for those we knew and the many we need to remember

To all my relatives and friends in Florida – keep safe, dry and let us know (I know you are saving cell battery strength) when time is appropriate

 

Out and about: Athersys (ATHX) takes a hit (-$0.06 or -2.87%) as Healios K.K. TREASURE P3 trial delayed again due to manufacturing issues with 1.36 M shares trade <3 month average = 758.6 K shares>

Pre-open indications: 3 hits and 2 miss

 

It’s called premium content for a reason: what is the value of reporting the truth in this sector?

If you had been right as many times as I have been in these many months of 2017 as a SUBSCRIBER you would know … who and when to get in and out or get back in again!

 

I answer one question, in which company should investors commit and keep their money.

 

 

Monday’s results have implications to Tuesday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

 

Henry’omics:

From the pre-open’s investor’s newsletter “… there’s no escape as the sector goes up and down for that’s what it does!”

Cell, stem and gene therapy companies moved from the opening upside, a downside mid-day to a barely positive close – again like Friday.

  • Feeling the gain was:  BLUE (+$2.10), ONCE (+0.85), KITE (+$0.44), BLCM and CLLS.

Of the mid-tiers, ADVM (+$0.20), STML (+$0.20), VSTM (still running at +$0.12), FATE (+$0.11) and PSTI (+$0.11, a surprise after Q4 and FY17 results and $26.7 M in cash as of 6/17), AXGN MDXG and ONVO were up along with QURE, JUNO and AGTC – who will finally announce their Q’s results.

  • Getting slammed was: ADRO (-$0.50), SGMO (-$0.15), CLBS (-$0.13) – for all their cash, investors just don’t believe in this CEO; ATHX, RGNX – it’s had a run and it was time and BLFS – it’s up but, more than very cash poor.

Getting dumped in the relationship with sentiment was:  a consistent dud – PSTI.

My customary target were down: BSTG with serious terminal death legal issue hanging over its head and CYTX – who is restructuring and looking for a future … their CEOs are the problem and their tactical execution.

  • AST was up +$0.10 while the mothership, BTX was flat at $2.84.

Under estimated companies: VCEL closed down -$0.05 after being flat on Friday following Thursday’s up +$0.15 after being flat at $4.30 with approved products and HSGX  was up again +$0.03 after Friday’s +$0.03 following a close of +$0.08 after the previous day’s -$0.05 with a P3 milestone.

 

I was surprised as the sector felt some strength after the mid-day. Today’s closing and the lack of continued downside could confuse many an investors but, the upside moves just delays the overbought becoming the oversold!

There is still the issue of resistance and can or will be an issue of” interruptus”?

 

 

Pre-open indications: 3 hits and 2 miss:

  • Fibrocell Science (FCSC) closed down -$0.02 – hit;
  • Athersys (ATHX) closed down -$0.06 – hit;
  • bluebird bio (BLUE) closed up +$2.10 – miss;
  • Sangamo Therapeutics (SGMO) closed down -$0.15 – miss;
  • Verastem (VSTM) closed up +$0.12 – hit;

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The first hour was positive with an A/DL of 23/15 and 5 flat;

·         The mid-day was negative with an A/DL of 15/24 and 4 flat;

·         The close was positive with an A/DL of 23/20 and 0 flat ;

 

 

Out and about:

Athersys (ATHX) takes a hit as Healios K.K. TREASURE P3 trial delayed again due to manufacturing issues. Potential partnerships negotiations may be impacted by complications with manufacturing of clinical product and associated controls.

  • ATHX is down -0.10 or -4.78% to $1.99 with 1.16 M shares traded <3 month average = 758.6 K shares>

 

Daily analytics:

U.S. stock-index benchmarks closed sharply higher on Monday.

·         The Dow closed about 259.58 points, or 1.2%, higher at 22,057.37.

·         The S&P 500 index climbed 1.1% at 2,488.11, marking a fresh record for the broad-market gauge.

·         The NASDAQ rallied 1.1% at 6,432.26, and ended within range of its all-time closing high.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Monday traded at 10.73, down -11.47% …

Friday traded at 12.12, up +4.94% after Thursday traded 11.88, down -0.69% after Wednesday traded at 11.63, down -4.91%, Tuesday traded at 12.23, up +20.73%, and last Monday was a holiday

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Monday was up +1.03%

·         Friday +0.07%

·         Thursday -0.25%

·         Wednesday +0.20%

·         Tuesday -0.95%

·         Last Monday was a holiday

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Monday was up +0.09%

·         Friday -0.34%

·         Thursday +0.27%

·         Wednesday +0.39%

·         Tuesday -0.83%

·         Last Monday was a holiday

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %

·         Monday’s decliners ranged from -0.19% <RGNX -$0.05> to -4.29% <ADRO -$0.50> in 20 equities;

·         Friday’s decliners ranged from -0.15% <KITE -$0.27> to -8.19% <MDXG -$1.27> in 16 equities;

·         Thursday’s decliners ranged from -0.21% <BLFS -$0.01> to -6.82% <VTGN -$0.12> in 11 equities;

·         Wednesday’s decliners ranged from -0.28% <AXGN -$0.05> to -7.71% <CYTX -$0.03> in 22  equities;

·         Tuesday’s decliners ranged from -0.04% <KITE -$0.07> to -20.26% <CLLS -$6.52> in 27  equities;

·         Last Monday was a holiday

Versus

… Look at the percentage’s (%) and spreads …

·         Friday’s gainers ranged from +0.14% <JUNO +$0.06> to +9.40% <PSTI +$0.11> in 23 equities;

·         Friday’s gainers ranged from +0.15% <XON +$0.03> to +15.63% <CYTX +$0.05> in 20 equities;

·         Thursday’s gainers ranged from +0.21% <KITE +$0.38> to +16.13% <FCSC +$0.40> in 28 equities;

·         Wednesday’s gainers ranged from +0.08% <KITE +$0.14> to +28.13% <VSTM +$1.08> in 18 equities;

·         Tuesday’s gainers ranged from +0.21% <CYTX +$0.01> to +19.95% <ISCO +$0.24> in 13 equities;

·         Last Monday was a holiday

 

Some of MY working trend lines or indications:

… The greatest volume to the downside:  ATHX, SGMO, IMUC, RENE.L and NWBO

… Upside volume was weighted to:  KITE, VSTM, MDXG, JUNO and ONVO

… Biggest $ downside:  ADRO, SGMO, CLBS, ATHX and RGNX

… Largest $ upside:  BLUE, ONCE, KITE, CLLS and BLCM

… Flat:  None

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.